These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34644561)

  • 1. Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome.
    Ho JJD; Cunningham TA; Manara P; Coughlin CA; Arumov A; Roberts ER; Osteen A; Kumar P; Bilbao D; Krieger JR; Lee S; Schatz JH
    Cell Rep; 2021 Oct; 37(2):109806. PubMed ID: 34644561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
    Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
    Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol.
    Müller C; Obermann W; Schulte FW; Lange-Grünweller K; Oestereich L; Elgner F; Glitscher M; Hildt E; Singh K; Wendel HG; Hartmann RK; Ziebuhr J; Grünweller A
    Antiviral Res; 2020 Mar; 175():104706. PubMed ID: 31931103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules.
    Singh K; Lin J; Lecomte N; Mohan P; Gokce A; Sanghvi VR; Jiang M; Grbovic-Huezo O; Burčul A; Stark SG; Romesser PB; Chang Q; Melchor JP; Beyer RK; Duggan M; Fukase Y; Yang G; Ouerfelli O; Viale A; de Stanchina E; Stamford AW; Meinke PT; Rätsch G; Leach SD; Ouyang Z; Wendel HG
    Cancer Res; 2021 Apr; 81(8):2002-2014. PubMed ID: 33632898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors.
    Chu J; Zhang W; Cencic R; Devine WG; Beglov D; Henkel T; Brown LE; Vajda S; Porco JA; Pelletier J
    Cell Chem Biol; 2019 Nov; 26(11):1586-1593.e3. PubMed ID: 31519508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of a biotinylated rocaglate: Selective targeting of the translation factors eIF4AI/II.
    Chambers JM; Lindqvist LM; Savage GP; Rizzacasa MA
    Bioorg Med Chem Lett; 2016 Jan; 26(2):262-264. PubMed ID: 26718843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.
    Iwasaki S; Floor SN; Ingolia NT
    Nature; 2016 Jun; 534(7608):558-61. PubMed ID: 27309803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A.
    Chu J; Galicia-Vázquez G; Cencic R; Mills JR; Katigbak A; Porco JA; Pelletier J
    Cell Rep; 2016 Jun; 15(11):2340-7. PubMed ID: 27239032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer.
    Wolfe AL; Singh K; Zhong Y; Drewe P; Rajasekhar VK; Sanghvi VR; Mavrakis KJ; Jiang M; Roderick JE; Van der Meulen J; Schatz JH; Rodrigo CM; Zhao C; Rondou P; de Stanchina E; Teruya-Feldstein J; Kelliher MA; Speleman F; Porco JA; Pelletier J; Rätsch G; Wendel HG
    Nature; 2014 Sep; 513(7516):65-70. PubMed ID: 25079319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation Inhibition by Rocaglates Activates a Species-Specific Cell Death Program in the Emerging Fungal Pathogen Candida auris.
    Iyer KR; Whitesell L; Porco JA; Henkel T; Brown LE; Robbins N; Cowen LE
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.
    Bordeleau ME; Robert F; Gerard B; Lindqvist L; Chen SM; Wendel HG; Brem B; Greger H; Lowe SW; Porco JA; Pelletier J
    J Clin Invest; 2008 Jul; 118(7):2651-60. PubMed ID: 18551192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA.
    Iwasaki S; Iwasaki W; Takahashi M; Sakamoto A; Watanabe C; Shichino Y; Floor SN; Fujiwara K; Mito M; Dodo K; Sodeoka M; Imataka H; Honma T; Fukuzawa K; Ito T; Ingolia NT
    Mol Cell; 2019 Feb; 73(4):738-748.e9. PubMed ID: 30595437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F.
    Chu J; Zhang W; Cencic R; O'Connor PBF; Robert F; Devine WG; Selznick A; Henkel T; Merrick WC; Brown LE; Baranov PV; Porco JA; Pelletier J
    Cell Rep; 2020 Feb; 30(8):2481-2488.e5. PubMed ID: 32101697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
    Steinhardt JJ; Peroutka RJ; Mazan-Mamczarz K; Chen Q; Houng S; Robles C; Barth RN; DuBose J; Bruns B; Tesoriero R; Stein D; Fang R; Hanna N; Pasley J; Rodriguez C; Kligman MD; Bradley M; Rabin J; Shackelford S; Dai B; Landon AL; Scalea T; Livak F; Gartenhaus RB
    Blood; 2014 Dec; 124(25):3758-67. PubMed ID: 25320244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A forward genetic screen identifies modifiers of rocaglate responsiveness.
    Shen L; Pugsley L; Cencic R; Wang H; Robert F; Naineni SK; Sahni A; Morin G; Zhang W; Nijnik A; Porco JA; Langlais D; Huang S; Pelletier J
    Sci Rep; 2021 Sep; 11(1):18516. PubMed ID: 34531456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual targeting of DDX3 and eIF4A by the translation inhibitor rocaglamide A.
    Chen M; Asanuma M; Takahashi M; Shichino Y; Mito M; Fujiwara K; Saito H; Floor SN; Ingolia NT; Sodeoka M; Dodo K; Ito T; Iwasaki S
    Cell Chem Biol; 2021 Apr; 28(4):475-486.e8. PubMed ID: 33296667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress Granule-Inducing Eukaryotic Translation Initiation Factor 4A Inhibitors Block Influenza A Virus Replication.
    Slaine PD; Kleer M; Smith NK; Khaperskyy DA; McCormick C
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29258238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MATRIX platform to analyze translation machinery remodeling in glioblastoma cells.
    Ho JJD; Cunningham TA; Krieger JR; Schatz JH; Lee S
    STAR Protoc; 2022 Dec; 3(4):101919. PubMed ID: 36595908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation Inhibition by Rocaglates Is Independent of eIF4E Phosphorylation Status.
    Chu J; Cencic R; Wang W; Porco JA; Pelletier J
    Mol Cancer Ther; 2016 Jan; 15(1):136-41. PubMed ID: 26586722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties.
    Nilewski C; Michels TD; Packard GK; Xiang AX; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Ernst JT; Reich SH
    Bioorg Med Chem Lett; 2021 Sep; 47():128111. PubMed ID: 34353608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.